Zobrazeno 1 - 10
of 332
pro vyhledávání: '"Stephen C Textor"'
Autor:
Kai Jiang, Christopher M Ferguson, Abdelrhman Abumoawad, Ahmed Saad, Stephen C Textor, Lilach O Lerman
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219605 (2019)
ObjectivesTo validate and adapt a modified two-compartment model, originally developed for magnetic resonance imaging, for measuring human single-kidney glomerular filtration rate (GFR) and perfusion using dynamic contrast-enhanced computed tomograph
Externí odkaz:
https://doaj.org/article/3ee56ccd8b7b4d4ca8f18a1daf74378f
Autor:
Behzad Ebrahimi, Alfonso Eirin, Zilun Li, Xiang-Yang Zhu, Xin Zhang, Amir Lerman, Stephen C Textor, Lilach O Lerman
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e67474 (2013)
Atherosclerotic renal artery stenosis (ARAS) raises blood pressure and can reduce kidney function. Revascularization of the stenotic renal artery alone does not restore renal medullary structure and function. This study tested the hypothesis that add
Externí odkaz:
https://doaj.org/article/d07ff57ebabd42fea8f04518226371a8
Autor:
Franz H. Messerli, Chirag Bavishi, Jana Brguljan, Michel Burnier, Stephan Dobner, Fernando Elijovich, Keith C. Ferdinand, Sverre Kjeldsen, Cheryl L. Laffer, C. Venkata S Ram, Emrush Rexhaj, Luis M. Ruilope, Evgeniya V. Shalaeva, George C.M. Siontis, Jan A. Staessen, Stephen C. Textor, Wanpen Vongpatanasin, Liffert Vogt, Massimo Volpe, Jiguang Wang, Bryan Williams
Publikováno v:
Journal of hypertension, 40(10), 1859-1875. Lippincott Williams and Wilkins
Even though it has been more than a decade since renal denervation (RDN) was first used to treat hypertension and an intense effort on researching this therapy has been made, it is still not clear how RDN fits into the antihypertensive arsenal. There
Autor:
Nattawat Klomjit, Xiang-Yang Zhu, Alfonso Eirin, Aditya S Pawar, Sabena M Conley, Amrutesh S Puranik, Christopher M Ferguson, Seo Rin Kim, Hui Tang, Kyra L Jordan, Ishran M Saadiq, Amir Lerman, Joseph P Grande, Stephen C Textor, Lilach O Lerman
Publikováno v:
Nephrol Dial Transplant
Background Renal artery stenosis (RAS) is an important cause of chronic kidney disease and secondary hypertension. In animal models, renal ischemia leads to downregulation of growth factor expression and loss of intrarenal microcirculation. However,
Autor:
Adrian Santelli, In O. Sun, Alfonso Eirin, Abdelrhman M. Abumoawad, John R. Woollard, Amir Lerman, Stephen C. Textor, Amrutesh S. Puranik, Lilach O. Lerman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 11 (2019)
Background Hypertension may be associated with renal cellular injury. Cells in distress release extracellular vesicles (EVs), and their numbers in urine may reflect renal injury. Cellular senescence, an irreversible growth arrest in response to a nox
Externí odkaz:
https://doaj.org/article/b74fa03596b2481db9849560d6985c61
Autor:
Xiao-jun Chen, Alfonso Eirin, Garvan C. Kane, Sanjay Misra, Stephen C. Textor, Amir Lerman, Lilach O. Lerman
Publikováno v:
International Journal of Hypertension, Vol 2019 (2019)
Background. Percutaneous transluminal renal angioplasty (PTRA) improves blood pressure (BP) and renal function only in selected patients with atherosclerotic renovascular disease (ARVD). Hyperuricemia is associated with elevated risk for hypertension
Externí odkaz:
https://doaj.org/article/66385019d6e0489a8358ae9a905ed3a5
Autor:
Alireza Khodadadi-Jamayran, Stephen C. Textor, Timothy B. Niewold, Xiangyang Zhu, Ian Taylor, Amir Lerman, Tamara Tchkonia, Lilach O. Lerman, Xiao Jun Chen, James L. Kirkland, Amrutesh S. Puranik, Seo Rin Kim, La Tonya J. Hickson, Bennett G. Childs, Kai Jiang
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery ste
Autor:
Kirsten L. Johansen, Pranav S. Garimella, Caitlin W. Hicks, Philip A. Kalra, Dearbhla M. Kelly, Sven Martens, Kunihiro Matsushita, Pantelis Sarafidis, Manish M. Sood, Charles A. Herzog, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Holger Reinecke, Zanfina Ademi, Tara I. Chang, Tim Clark, Chris Cooper, Michael Criqui, Áine de Bhailis, Marco De Carlo, Wolfram Döhner, Daniel T. Engelman, Gerry Fowkes, Darren Green, Allen Hamdan, Christian Heiss, Peter Huppert, Daniella Kadian-Dodov, Gregory Y.H. Lip, Jolanta Małyszko, Patrick B. Mark, Marius Miglinas, Patrick Murray, Chris Reid, Paul Rochon, Josiah Ruturi, Athanasios Saratzis, Mark J. Sarnak, Cathy M. Shanahan, Laura Solá, Ulf Teichgräber, Stephen C. Textor, Kazunori Toyoda, Angela Yee-Moon Wang, Chris X. Wong
Publikováno v:
Kidney International. 100:35-48
Chronic kidney disease (CKD) affects about 10% of all populations worldwide, with about 2 million people requiring dialysis. Although patients with CKD are at high risk of cardiovascular disease and events, they are often underrepresented or excluded
Autor:
Vivek, Bhalla, Stephen C, Textor, Joshua A, Beckman, Ana I, Casanegra, Christopher J, Cooper, Esther S H, Kim, James M, Luther, Sanjay, Misra, Gustavo S, Oderich
Publikováno v:
Hypertension. 79
Renovascular disease is a major causal factor for secondary hypertension and renal ischemic disease. However, several prospective, randomized trials for atherosclerotic disease failed to demonstrate that renal revascularization is more effective than
Autor:
Xiangyang Zhu, Hui Tang, Christopher M. Ferguson, Kyra L. Jordan, Amir Lerman, Mohsen Afarideh, Stephen C. Textor, Rahele A. Farahani, Alfonso Eirin, Lilach O. Lerman, Ishran M. Saadiq
Publikováno v:
J Cell Physiol
OBJECTIVE: Percutaneous transluminal renal angioplasty (PTRA) has been used to treat renovascular disease (RVD), a chronic condition characterized by renal ischemia and metabolic abnormalities. Mitochondrial injury has been implicated as a central pa